SK285666B6 - Mikrogranuly omeprazolu s vonkajšou vrstvou, ktorá chráni pred žalúdočným prostredím, spôsob prípravy mikrogranúl - Google Patents

Mikrogranuly omeprazolu s vonkajšou vrstvou, ktorá chráni pred žalúdočným prostredím, spôsob prípravy mikrogranúl Download PDF

Info

Publication number
SK285666B6
SK285666B6 SK1141-2000A SK11412000A SK285666B6 SK 285666 B6 SK285666 B6 SK 285666B6 SK 11412000 A SK11412000 A SK 11412000A SK 285666 B6 SK285666 B6 SK 285666B6
Authority
SK
Slovakia
Prior art keywords
microgranules
hydrophobic
microgranules according
omeprazole
agent
Prior art date
Application number
SK1141-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK11412000A3 (sk
Inventor
Patrice Debregeas
G�Rard Leduc
Pascal Oury
Pascal Suplie
Original Assignee
Ethypharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9522415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK285666(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ethypharm filed Critical Ethypharm
Publication of SK11412000A3 publication Critical patent/SK11412000A3/sk
Publication of SK285666B6 publication Critical patent/SK285666B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
SK1141-2000A 1998-01-30 1998-08-10 Mikrogranuly omeprazolu s vonkajšou vrstvou, ktorá chráni pred žalúdočným prostredím, spôsob prípravy mikrogranúl SK285666B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9801098A FR2774288B1 (fr) 1998-01-30 1998-01-30 Microgranules d'omeprazole gastroproteges, procede d'obtention et preparations pharmaceutiques
PCT/FR1998/001783 WO1999038511A1 (fr) 1998-01-30 1998-08-10 Microgranules d'omeprazole gastroproteges, procede d'obtention et preparations pharmaceutiques

Publications (2)

Publication Number Publication Date
SK11412000A3 SK11412000A3 (sk) 2001-04-09
SK285666B6 true SK285666B6 (sk) 2007-05-03

Family

ID=9522415

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1141-2000A SK285666B6 (sk) 1998-01-30 1998-08-10 Mikrogranuly omeprazolu s vonkajšou vrstvou, ktorá chráni pred žalúdočným prostredím, spôsob prípravy mikrogranúl

Country Status (32)

Country Link
US (1) US6551621B1 (de)
EP (1) EP1051174B2 (de)
JP (1) JP4286452B2 (de)
KR (1) KR100510366B1 (de)
CN (1) CN1114405C (de)
AT (1) ATE232100T1 (de)
AU (1) AU755882B2 (de)
BG (1) BG65087B1 (de)
BR (1) BR9814924B1 (de)
CA (1) CA2319015C (de)
CZ (1) CZ299192B6 (de)
DE (1) DE69811278T3 (de)
DK (1) DK1051174T4 (de)
EA (1) EA002879B1 (de)
EE (1) EE05620B1 (de)
ES (1) ES2189232T5 (de)
FR (1) FR2774288B1 (de)
GE (1) GEP20032941B (de)
HK (1) HK1032354A1 (de)
HU (1) HU229956B1 (de)
IL (1) IL137536A0 (de)
IS (1) IS2866B (de)
NO (1) NO330144B1 (de)
NZ (1) NZ505998A (de)
PL (1) PL200043B1 (de)
PT (1) PT1051174E (de)
RS (1) RS50245B (de)
SI (1) SI1051174T2 (de)
SK (1) SK285666B6 (de)
TR (1) TR200002214T2 (de)
UA (1) UA61988C2 (de)
WO (1) WO1999038511A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2790668B1 (fr) * 1999-03-12 2002-07-26 D B F Granules contenant une substance vegetale et leur procede de preparation
FR2793688B1 (fr) 1999-05-21 2003-06-13 Ethypharm Lab Prod Ethiques Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques
FR2845289B1 (fr) * 2002-10-04 2004-12-03 Ethypharm Sa Spheroides, procede de preparation et compositions pharmaceutiques.
CA2517005A1 (en) * 2003-02-20 2004-09-02 Santarus, Inc. A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
US20050220870A1 (en) * 2003-02-20 2005-10-06 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
ES2234393B2 (es) * 2003-04-29 2006-09-01 Laboratorios Belmac, S.A. "formulaciones de pelets de compuestos bencimidazolicos antiulcerosos y labiles al acido".
AR045062A1 (es) * 2003-07-18 2005-10-12 Santarus Inc Formulaciones farmaceuticas para inhibir la secrecion de acido y metodos para preparar y utilizarlas
MXPA06000524A (es) * 2003-07-18 2006-08-11 Santarus Inc Formulacion farmaceutica y metodo para tratar desordenes gastrointestinales provocados por acido.
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
KR101148734B1 (ko) * 2003-10-10 2012-07-05 에띠빠흠 징코 빌로바 추출물을 포함하는 서방형 미세과립 및 이것을 제조하는 방법
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
WO2005076987A2 (en) * 2004-02-10 2005-08-25 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent
CA2561700A1 (en) * 2004-04-16 2005-12-15 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and prokinetic agent
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
EP1768668A2 (de) * 2004-06-16 2007-04-04 Tap Pharmaceutical Products, Inc. Multi-ppi-dosierform
EP1965774A2 (de) * 2005-12-30 2008-09-10 Cogentus Pharmaceuticals, Inc. Orale pharmazeutische formulierungen mit nichtsteroidalen entzündungshemmern und säurehemmern
WO2007115305A2 (en) 2006-04-04 2007-10-11 Cogentus Pharmaceuticals, Inc. Oral dosage forms including an antiplatelet agent and an acid inhibitor
US20100297226A1 (en) * 2006-06-01 2010-11-25 Dexcel Pharma Technologies Ltd. Multiple unit pharmaceutical formulation
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
EP2081546A2 (de) * 2006-10-17 2009-07-29 Ranbaxy Laboratories Limited Tablettenzusammensetzungen mit mehreren einheiten von benzimidazol-verbindungen
BR112014016085A8 (pt) 2011-12-28 2017-07-04 Pozen Inc composições aprimoradas e métodos para distribuição de omeprazol mais ácido acetilsalicílico
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
EP3117824A1 (de) 2015-07-17 2017-01-18 BE Pharbel Manufacturing Mehrschichtige mikropartikel zur freigabe einer pharmazeutisch aktiven verbindung in einer flüssigen verabreichungsform
US20190008787A1 (en) 2015-07-17 2019-01-10 BE Pharbel Manufacturing Multilayered pharmaceutically active compound-releasing microparticles in a liquid dosage form
US10736855B2 (en) 2016-02-25 2020-08-11 Dexcel Pharma Technologies Ltd. Compositions comprising proton pump inhibitors
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
FR3078630B1 (fr) 2018-03-08 2021-05-14 Karim Ioualalen Mode de formulation sous forme de solide divise hydrophobe

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189698A (en) 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
JPH0768125B2 (ja) * 1988-05-18 1995-07-26 エーザイ株式会社 酸不安定化合物の内服用製剤
FR2692146B1 (fr) † 1992-06-16 1995-06-02 Ethypharm Sa Compositions stables de microgranules d'omeprazole gastro-protégés et leur procédé d'obtention.
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
EP0785984B1 (de) * 1994-09-30 2002-07-10 Medical Security Corporation Verfahren zum reinigen und rutschfesten behandlung von oberflächenbelägen
ES2094694B1 (es) † 1995-02-01 1997-12-16 Esteve Quimica Sa Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion.
CH687810A5 (de) 1995-05-24 1997-02-28 Mepha Ag Pelletformulierung mit Omeprazol.
DE69631834T2 (de) * 1995-09-21 2005-02-10 Pharma Pass Ii Llc, Irvine Neues ein säureempfindliches benzimidazol enthaltendes mittel und verfahren zu dessen herstellung
DE69729950T2 (de) * 1996-11-06 2005-07-28 Wockhardt Europe Ltd. Arzneimittel-Zuführsystem mit verzögerter Freisetzung für säurelabile Arzneistoffe
GB9710800D0 (en) * 1997-05-23 1997-07-23 Cipla Limited Pharmaceutical composition and method of preparing it
SE9704870D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
SE9704869D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulaton II

Also Published As

Publication number Publication date
EE05620B1 (et) 2013-02-15
RS50245B (sr) 2009-07-15
HUP0100347A2 (hu) 2001-10-28
DK1051174T3 (da) 2003-05-26
YU48400A (sh) 2003-02-28
DE69811278D1 (de) 2003-03-13
HK1032354A1 (en) 2001-07-20
JP2002501895A (ja) 2002-01-22
FR2774288B1 (fr) 2001-09-07
KR100510366B1 (ko) 2005-08-24
ES2189232T5 (es) 2012-11-07
KR20010040502A (ko) 2001-05-15
BG104634A (bg) 2001-02-28
CZ20002709A3 (cs) 2000-12-13
SK11412000A3 (sk) 2001-04-09
CA2319015C (fr) 2008-08-05
ATE232100T1 (de) 2003-02-15
CZ299192B6 (cs) 2008-05-14
ES2189232T3 (es) 2003-07-01
US6551621B1 (en) 2003-04-22
DK1051174T4 (da) 2012-10-01
CN1114405C (zh) 2003-07-16
NO20004654L (no) 2000-09-18
AU9074898A (en) 1999-08-16
EP1051174B2 (de) 2012-07-04
EE200000466A (et) 2002-04-15
NO330144B1 (no) 2011-02-21
GEP20032941B (en) 2003-04-25
IS2866B (is) 2014-01-15
BR9814924B1 (pt) 2010-07-13
HUP0100347A3 (en) 2002-12-28
HU229956B1 (hu) 2015-03-02
BG65087B1 (bg) 2007-02-28
UA61988C2 (uk) 2003-12-15
IS5577A (is) 2000-07-25
DE69811278T3 (de) 2012-11-29
AU755882B2 (en) 2003-01-02
TR200002214T2 (tr) 2000-12-21
SI1051174T2 (sl) 2013-01-31
PL200043B1 (pl) 2008-11-28
JP4286452B2 (ja) 2009-07-01
EA002879B1 (ru) 2002-10-31
FR2774288A1 (fr) 1999-08-06
SI1051174T1 (en) 2003-06-30
CA2319015A1 (fr) 1999-08-05
EA200000797A1 (ru) 2001-02-26
PT1051174E (pt) 2003-06-30
EP1051174B1 (de) 2003-02-05
IL137536A0 (en) 2001-07-24
BR9814924A (pt) 2000-10-17
CN1284877A (zh) 2001-02-21
EP1051174A1 (de) 2000-11-15
NO20004654D0 (no) 2000-09-18
WO1999038511A1 (fr) 1999-08-05
NZ505998A (en) 2003-11-28
PL342044A1 (en) 2001-05-21
DE69811278T2 (de) 2003-11-27

Similar Documents

Publication Publication Date Title
SK285666B6 (sk) Mikrogranuly omeprazolu s vonkajšou vrstvou, ktorá chráni pred žalúdočným prostredím, spôsob prípravy mikrogranúl
EP1185254B1 (de) Orale pharmazeutische formulierungen von benzimidazolderivaten und verfahren zu ihrer herstellung
US6623759B2 (en) Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
RU2214232C2 (ru) Пероральная фармацевтическая лекарственная форма с продолжительным высвобождением
FI119141B (fi) Menetelmä farmaseuttisen formulaation valmistamiseksi
US7255878B1 (en) Stable benzimidazole formulation
EP0960620A1 (de) Stabile orale pharmazeutische Zusammensetzung enthaltend ein Pyridylsulfinyl-substituiertes Benzimidazole
CZ87998A3 (cs) Směs obsahující acidolabilní omeprazol a způsob její přípravy
ZA200103336B (en) Pharmaceutical formulation comprising omeprazole.
SK280999B6 (sk) Mikroenkapsuláciou chuťovo maskovaný farmaceutický prostriedok a spôsob jeho výroby
CA2539982A1 (en) Pantoprazole multiparticulate formulations
JP2000514051A (ja) ベンズイミダゾール誘導体を活性成分とする経口投与用の安定な薬剤形およびその製造方法
JP2018521137A (ja) 液体剤形中の薬学的活性化合物放出性多層微小粒子
ES2667402T3 (es) Composición farmacéutica de omeprazol
KR20120104991A (ko) 약학적 고체 제형
BG65415B1 (bg) Микрогранули, неразтворими в стомашния сок, методза тяхното получаване и фармацевтични препарати
US20050191353A1 (en) Process for manufacture of stable oral multiple unit pharmaceutical composition containing benzimidazoles
WO2004089333A2 (en) A stable benzimidazole formulation
US20100105738A1 (en) Extended release formulations of a proton pump inhibitor
CN111789808A (zh) 口服医药组成物及其结构
KR20050093985A (ko) 판토프라졸 함유 경질 캡슐 제제 및 그 제조방법
WO2001037834A1 (en) Stable acid labile benzimidazole pharmaceutical compositions

Legal Events

Date Code Title Description
MK4A Expiry of patent

Expiry date: 20180810